← Back to Search

Patient Navigation for Gout (CARE-Gout Trial)

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥ 18 years old

Able to communicate and understand English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve the care for patients with gout, a painful joint condition that is becoming more common in the Southeastern U.S. The study also wants to increase the participation of minorities in

Who is the study for?

This trial is for individuals who have recently visited the emergency department (ED) for gout, a type of arthritis caused by excess uric acid. The study focuses on improving long-term care and acute treatment in the Southeastern U.S., with an emphasis on including African Americans.

What is being tested?

The intervention being tested is 'Patient Navigation,' which may involve personalized guidance and support to help patients manage their gout after an ED visit. The goal is to improve overall care and encourage minority participation in research.

What are the potential side effects?

Since this trial involves patient navigation rather than medication or medical procedures, there are no direct side effects associated with traditional clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I can communicate and understand either English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Follow-Up Visit Addressing Gout within 3 Months

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Patient NavigationExperimental Treatment1 Intervention

A lay patient navigator will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.

Group II: ControlActive Control1 Intervention

Usual Care

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient Navigation

2017

Completed Phase 2

~38910

0 / 2Eligibility criteria met